Search
Search
{{#data.error.root_cause}}
{{/data.error}}
{{^data.error}}
[{{{type}}}] {{{reason}}}
{{/data.error.root_cause}}
{{#data.hits.hits}}
{{#_source.featured}}
FEATURED
{{/_source.featured}}
{{#_source.showImage}}
{{#_source.image}}
{{/_source.image}}
{{/_source.showImage}}
{{/data.hits.hits}}
{{{_source.title}}} {{#_source.showPrice}} {{{_source.displayPrice}}} {{/_source.showPrice}}
{{#_source.showLink}} {{/_source.showLink}} {{#_source.showDate}}{{{_source.displayDate}}}
{{/_source.showDate}}{{{_source.description}}}
{{#_source.additionalInfo}}{{#_source.additionalFields}} {{#title}} {{{label}}}: {{{title}}} {{/title}} {{/_source.additionalFields}}
{{/_source.additionalInfo}}EpitoGen Immunity COVID-19 ELISA Test
(Cat#: EPITO-IM)
Description
With the COVID-19 pandemic underway, a novel epitope/peptide expression platform, EpitoGen Technology, has been developed to produce a set of unique, highly sensitive COVID-19 ELISA tests.
EpitoGen Technology efficiently expresses short epitopes to vastly improve antibody tests. The epitope antigen (EpitoGen) is fused in the middle of an inert scaffold protein and displayed on the top of the scaffold ideally suited for a number of antigen/antibody-based assays such as ELISA and lateral flow.
The EpitoGen Immunity COVID-19 ELISA test is designed to detect the IgG antibody response to non-spike proteins and their corresponding mutants (N, M, ORF3a and ORF7a, 29 prevalent mutations), the reference spike protein used in vaccine development, and major mutants of the spike protein (16 prevalent mutations). It can be used before and after COVID-19 infection or vaccination to provide a readout of immunity against further infection by the reference strain or mutated variants.
This EpitoGen Test includes the IgG ELISA plate and dilution buffer. Other materials are to be supplied by the user.
Discounts are available for bulk quantities. Inquire for pricing.
Please note: This product is for research use only.
- Efficiently expresses short epitopes to improve antibody tests
- Determines immunity against further infection
- 95-100% sensitivity and 99% specificity
- Easily integrated into existing ELISA protocols
- Highly stable components are easy to ship and store
- Evaluation of COVID-19 antibody response following vaccination or natural infection, and against the original and mutant COVID-19
- Detection of IgM and IgA to evaluate active COVID-19 infection or mucosal immunity
- EpitoGen Immunity 96 well COVID-19 IgG ELISA plate
- Diluent
- 20 single tests or 10 duplicate tests per plate
Related Categories
COVID-19 Research